{"title":"EDITORIAL\nAlcances de la revista Investigación Clínica durante el año 2023.","authors":"E. Ryder","doi":"10.54817/ic.v65n1a00","DOIUrl":null,"url":null,"abstract":"The main achievement of the journal in 2023 was an increase in the number of works received, mainly of foreign origin. The rejection percentage was 36%. The evaluation of the work of the members of the Editorial Committee had the collaboration of external referees from national and foreign institutions, especially Venezuelans living abroad. The magazine fulfilled its frequency of four issues with 41 communications in 559 pages, exceeding the number of pages from the previous year. Among the 41 works, the original works in English predominated, both from Venezuela and Latin America and countries on other continents. In evaluating the magazine by international indices, the increase in the Copernicus Index score stands out due to excellent compliance with their classification patterns. There were discrepancies between the different indexes in the citations; Clarivate reported 204, and Sco-pus only 20. Scopus recognizes only 44 citations in the four years (2019-2022), and Scielo recognizes 498 in that same period. The Crossref report was of more than 13,000 accesses in 2023, with Spanish-language Reviews being the most frequent, which suggests that Latin America is the primary source of readers for the magazine. This observation corroborates the results of our website, where the main accesses come from American countries. We hope that in 2024, Investigación Clínica will increase its national and international recognition; it would be a gift to the memory of its founder, Américo Negrette, who would be celebrating the centenary of his birth in 2024.","PeriodicalId":14515,"journal":{"name":"Investigación Clínica","volume":"58 14","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Investigación Clínica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54817/ic.v65n1a00","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The main achievement of the journal in 2023 was an increase in the number of works received, mainly of foreign origin. The rejection percentage was 36%. The evaluation of the work of the members of the Editorial Committee had the collaboration of external referees from national and foreign institutions, especially Venezuelans living abroad. The magazine fulfilled its frequency of four issues with 41 communications in 559 pages, exceeding the number of pages from the previous year. Among the 41 works, the original works in English predominated, both from Venezuela and Latin America and countries on other continents. In evaluating the magazine by international indices, the increase in the Copernicus Index score stands out due to excellent compliance with their classification patterns. There were discrepancies between the different indexes in the citations; Clarivate reported 204, and Sco-pus only 20. Scopus recognizes only 44 citations in the four years (2019-2022), and Scielo recognizes 498 in that same period. The Crossref report was of more than 13,000 accesses in 2023, with Spanish-language Reviews being the most frequent, which suggests that Latin America is the primary source of readers for the magazine. This observation corroborates the results of our website, where the main accesses come from American countries. We hope that in 2024, Investigación Clínica will increase its national and international recognition; it would be a gift to the memory of its founder, Américo Negrette, who would be celebrating the centenary of his birth in 2024.